tiprankstipranks
Kneat Secures Major Agreement with Global Therapeutics Leader
Company Announcements

Kneat Secures Major Agreement with Global Therapeutics Leader

Story Highlights

Stay Ahead of the Market:

The latest update is out from kneat.com ( (TSE:KSI) ).

Kneat.com has announced a three-year Master Services Agreement with a major global therapeutics company to digitize its validation processes using Kneat Gx. This partnership highlights Kneat’s growing influence in the Life Sciences industry, as it supports the therapeutics company, which operates in over 100 countries and serves millions of patients, on their digital transformation journey.

More about kneat.com

Kneat Solutions is a leader in digitizing and automating validation and quality processes for highly regulated industries. Its digital validation platform, Kneat Gx, is ISO 9001 and ISO 27001 certified, and complies with 21 CFR Part 11/Annex 11 standards. The platform is recognized for its efficiency, user-friendly design, expert support, and training resources, offering up to a 40% reduction in manual effort and validation documentation cycle times.

YTD Price Performance: 2.39%

Average Trading Volume: 80,363

Technical Sentiment Consensus Rating: Sell

Current Market Cap: C$562.4M

Learn more about KSI stock on TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App